SOMERVILLE, Mass., May 2, 2024 /PRNewswire/ -- Matterworks, Inc.,
whose foundational AI platform and predictive biology applications
accelerate life sciences discovery and development, today announces
additions to its leadership team.
Matterworks is pleased to announce the appointments of
Jennifer M. Campbell, Ph.D. to the
position of Chief Scientific Officer and Niall O'Connor to the position of Chief
Technology Officer.
Dr. Campbell is a distinguished leader in mass spectrometry and
molecular analysis, bringing 25 years of expertise to the role. She
joined Matterworks from Novartis Institutes of Biomedical Research
in 2021 to lead R&D from initial product conceptualization
through development and early customer testing. In late 2023 Dr.
Campbell accepted the role of Chief Scientific Officer.
Dr. Campbell has led R&D mass spectrometry projects at both
Applied Biosystems and Perkin Elmer, as well as leading Proteomics
R&D for Systems Biology at BG Medicine. Her experience also
includes scientific development of Perkin Elmer's NeoBase 2, which
is approved for use in newborn screening in over 100 countries
worldwide, and the MALDI TOF/TOF product line at Applied
Biosystems.
Mr. O'Connor is a product and technology leader in the
healthcare and life sciences spaces. Prior to joining Matterworks,
he served as the Chief Technology Officer at Cohere Health, where
he led the development of AI and ML products to automate
high-quality clinical decision-making.
In 2012, O'Connor co-founded Genospace, a cloud-based software
company focused on the interpretation of molecular genomics data in
combination with clinical data to deliver oncology personalized
medicine at the bedside. Genospace was acquired by Sarah Cannon, the Cancer Institute of HCA
Healthcare (NYSE: HCA) in 2017.
"I could not be more thrilled to have Jenn Campbell and Niall
O'Connor as part of the Matterworks organization," said Dr.
Jack Geremia, Matterworks CEO.
"Jenn's deep expertise and creativity in the molecular sciences
plus Niall's exceptional track record for building and scaling
software that delivers breakthrough technologies to life-sciences
users and environments is a potent combination. Their talents
will advance Matterworks into our next phase of technology
leadership and commercial deployment."
About Matterworks
Matterworks is pioneering advances
in AI that reveal insights otherwise hidden within the immense
complexity of biological data. Our Large Spectral Model (LSM)
platform is reinventing the analysis and interpretation of omic
measurements. To learn more, visit
https://www.matterworks.ai.
View original
content:https://www.prnewswire.com/news-releases/matterworks-announces-updates-to-leadership-team-302134620.html
SOURCE Matterworks